Blog
Planify news
Lenskart in talks for 200 million infusion from Temasek, Fidelity, eyeing $5 billion valuation
  • Lenskart in talks for 200 million infusion from Temasek, Fidelity, eyeing $5 billion valuation

    25 April 2024

    Lenskart is engaged in talks with Temasek and Fidelity for a $200 million funds infusion through a secondary share sale, The Economic Times reported citing sources.


    A significant increase from its previous valuation, this move would also place Lenskart's worth at over three times that of competitor Warby Parker, the report added. A New York-based online eyewear retailer, Warby Parker went public on the NYSE in 2022 with a market cap of close to $1.55 billion.

    Image

    Stay Connected, Stay Informed –

    Join Our

    WhatsApp

    Channel!

    Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.